期刊文献+

食管癌患者血清胸苷激酶1检测的外科临床意义 被引量:3

下载PDF
导出
摘要 目的探讨血清胸苷激酶1(thymidine kinase 1,TK1)检测对食管癌辅助诊断及术后效果评估的意义。方法应用免疫印迹—增强化学发光法(ECL)检测348例食管癌手术患者术前、术后1周以及手术1~3个月的血清TK1水平,另外加入41例健康体检者作为对照组,检测其血清TK1水平,并对部分术后患者随访12个月。结果食管癌患者血清TK1水平明显高于健康对照组(P<0.05);癌患者手术后1周,血清TK1水平明显上升(P<0.05),而在术后1~3个月回落,并明显低于术前水平(P<0.05);完成对45例患者12个月随访,发现术后1~3个月TK1水平上升患者复发比例远远大于下降组(P<0.001)。结论血清TK1水平反映细胞增殖,连续跟踪结果有利于对食管癌手术治疗效果的辅助诊断,对临床监视肿瘤手术疗效,判断复发风险具有临床意义。
出处 《中国医药指南》 2011年第33期305-307,共3页 Guide of China Medicine
  • 相关文献

参考文献14

  • 1Zhang F,L i H,Pendleton AR,et al.Thymidine kinase 1 immunoassay:a potential marker for breast cancer[J].CancerDetect Prev,2001,25 (1):8-15.
  • 2Li Hx,Lei DS,Wang QX,et al.Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer.Oncol Rep,2005,13(2):145-149.
  • 3He Q,Zhang P,Zou L,et al.Concentration of thymidine kinase 1 in serum(S-TKI)is a more sensitive proliferation marker in human solid tumors than its activity[J].Oncol Rep,2005,14(4):1013-1019.
  • 4Zhang J,Jia Q,Zou S,et al.Thymidine kinase 1:a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients[J].Oncol Rep,2006,15(5):455-461.
  • 5He Q,Fornander T,Johansson H,et a1.Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer[J].Anticancer Res,2006,26(6C):4753-4759.
  • 6Wu C,Yang R,Zhou J,et al.Production and characterisation of a novel chicken IgY antibody raised against C?terminal peptide from human thymidine kinase 1[J].J Immunol Methods,2003,277 (2):157-169.
  • 7Chen Z,Zhou H,Li S,et al.Serological thymidine kinase 1 (STK1)indicates an elevated risk for the development of malignant turnouts[J].Anticancer Res,2008,28(6B):3897-3907.
  • 8Arnér ES,Eriksson S.Mammalian deoxynucleoside kinase.J Pharmacol Ther,1995,67 (2):155-186.
  • 9Gasparri F,Wang N,Skog S,et al.Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site specific antibodies and ArrayScan assays[J].J Eur J Cell Biol,2009,88(12):779-785.
  • 10郭林,卢仁泉.胃癌患者血清胸苷激酶检测的临床意义[J].检验医学,2008,23(3):271-273. 被引量:25

二级参考文献31

  • 1Zhang F, Li H, Pendleton AR, et al. Thymidine kinase 1 immunoassay: a potential marker for breast cancer [ J ]. Cancer Detect Prev ,2001,25 ( 1 ) :8-15.
  • 2Gesing A, Modrzejewska H, Karbownik M, et al. Thymidine kinase and adenosine kinase activities in homogenates of thyroid lobes in hemithy - roidectomized rats; effects of melatonin in vitro[ J ]. Neuroendocrinol Lett ,2000,21 ( 6 ) : 453-459.
  • 3Demeter A,Abonyi M, Look KY, et al. Differences in thermoslability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma [ J ]. Anti cancer Res, 2001 , 21 (IA) :353-358.
  • 4HallekM ,Touitou Y, Levi F, et al. Serum thymidine kinase levels are elevated exhibitdiurnal variations in patientswith advanced ovarian cancer[ J]. Clin Chim Acta, 1997, 267 (2) : 155-166.
  • 5He Q, Skog S, Wang N, et al. Characterization of a peptide antibody against a C - terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation[ J ]. Eur J Cell Biol, 1996,70 ( 2 ) : 117- 124.
  • 6Zhang F, Li H, Pendleton AR, et al. Thymidine kinase 1 immunoassay:a potential marker for breast cancer [ J ]. Cancer Detect Prey,2001,25 ( 1 ) :8-15.
  • 7LiHX, LeiDS, WangXQ, et al. Serum thymidine ki - nase 1 is a prognostic and monitoring factor in patients with non - small cell lung cancer[ J ]. Oncol Rep ,2005,13 ( 1 ) : 145- 149.
  • 8Zhang J,JiaQ,Zou S,et al. Thymidine kinase 1 : a proliferation marker for determining prognosis and monitoring the surgical out - come of primary bladder carcinoma patients [ J ]. Oncol Rep ,2006,15 ( 2 ) :455-461.
  • 9Ulmert D,Cronin AM,Bjork T,et al. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later:a casecontrol study [J]. BMC Med, 2008,6 : 6.
  • 10Zhang J,Jia Q,Zou S,et al. Thymidine kinase 1:a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients[J]. Oncol Rep,2006, 15(2) :455-461.

共引文献30

同被引文献46

  • 1顾光大.血清胃蛋白酶原、胸苷激酶联合检测对胃癌的诊断意义[J].实用医学杂志,2009,25(5):715-717. 被引量:14
  • 2曾智杰,欧阳文婷,孙艳虹,蔡小华.胸苷激酶1在白血病患者化疗过程中的临床意义探讨[J].分子诊断与治疗杂志,2009,1(1):28-30. 被引量:12
  • 3Munch-Petersen B. Enzymatic regulation of cytosolic thymidine kinase 1 and mitochondrial thymidine kinase 2 :a mini review[J]. Nueleosides Nucleotides Nucleic Acids, 2010,29 (4/6) : 363-369.
  • 4He q, Skog S, Wang N, et al. Characterization of a peptide anti- body against a C-terminal part of human and mouse cytosolic thy- midine kinase, which is a marker for cell proliferation[J]. Eur J Cell Bio1,1996,70(2) :117- 124.
  • 5Weissman SM,Smellie RM,Paul J. Studies on the biosynthesis of deoxyribonucleic acid by extracts o{ mammalian cells. The phos- phorylation of thymidine[J]. Biochim Biophys Acta, 1960,45 (4) 101-110.
  • 6Xu Y,Shi OL, Ma H, et al. High thymidine kinase I(TK1) ex- pression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma[J]. Tumour Biol,2012,33(2) :475-483.
  • 7Li HX, Lei DS,Wang XQ, et al. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer[J]. Oncol Rep,2005,13(1) :145-149.
  • 8Huang S, Lin J, Guo N, et al. Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression [ J]. Asian Pac J Cancer Prey ,2011,12 ( 2 ) :497 - 505.
  • 9Aufderklamm S, Todenhofer T, Gakis G, et al. Thymidine kinase and cancer monitoring [J]. Cancer Lett,2012,316( 1 ) :6 - 10.
  • 10Hitesh KA, Craig AM, Elena S, et al. Synthesis of N3 - subsituted carborangl thymidine bioconjugates and their evaluation as sub- strates of recombinant human thymidine kinase 1 [ J ]. E:repean Journal Medicinal Chemistry ,2013,60( 1 ) :456 -468.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部